A systematic review of dozens of research papers has found that ketamine therapy has a quick, short-term effect of reducing depression symptoms and suicidal thoughts, making it a promising mental health treatment alternative.
Gold edges back to start trade in final week of 2021
Gold futures were retreating from a five-week high but were holding above the psychologically significant price at $1,800 in the final week of trading in 2021.
MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety Disorder
MindMed announces that the FDA has placed "clinical hold" on its initial IND submission in preparation for its Phase 2b clinical trial for generalized anxiety disorder (GAD).
Gold sees moderate price gains; bulls have advantage
Gold prices are modestly up in early U.S. trading, as the near-term technical posture for the yellow metal is bullish.
Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics
Novamind announces a definitive agreement to acquire Arizona-based Foundations for Change, PLC.
The Military Mental Health Crisis, A National Tragedy: Part II
In Part II, we take a personal look at the journey into PTSD Hell. We also examine the additional serious issues facing veterans attempting to cope with PTSD.
Gold, silver gain amid friendly outside markets
Gold and silver prices are moderately higher in midday U.S. trading Wednesday.
Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase Safety, Efficacy, and Accessibility of Psychedelic-Assisted Treatments
Mydecine announces an LOI to co-develop its own digital therapeutics platform, in partnership with Maya Health.
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
Optimi Health receives its Health Canada Dealers' License and initiates new Quality Assurance Department.
Cybin Provides 2021 Year End Summary
Cybin Inc provides a year-end update highlighting drug and IP development as well as international expansion.
Gold price holds steady as investors assess omicron risk
Gold prices held steady, hovering close to a three-week peak, as the spread of the omicron coronavirus variant continues to smother investors’ appetite for riskier assets, lifting bullion’s safe-haven appeal.
Price rebounds for gold, silver; risk aversion recedes
A rebound in the crude oil market today and a weaker U.S. dollar index are friendly outside market forces supporting the metals.
